Clinical laboratories large and small are experiencing increased scrutiny from the federal government, states and private insurers.  This focus has developed because payers have identified several areas in which they believe improper billing is occurring.

In this presentation, Dr. Daly discusses areas of regulatory concern and individual liability.

About The Author

Prior to his role as Chief Medical Officer at COLA, Dr. John Daly was the Director of Clinical Laboratories for the Duke University Health System from 2005-2009. A longtime resident of Durham, NC, Dr. Daly was quite active in the local medical community, joining the staffs of three area hospitals and serving as a member of various hospital committees. He earned his M. D. at Cornell University Medical College, and performed his internship and residency in pathology at Duke University Medical Center. He also is a veteran of the U. S. Navy.

Related Posts

Send this to a friend